Pharmaceutical Services Negotiating Committee

Updated COVID-19 SOP: volunteers liability clarified and opening hours flexibility removed

Update on new flexible approaches to flu vaccination service

Initial information on the Part 2 PQS for 2020/21

Further details on the national flu immunisation programme announced

PPE portal: now live for Community Pharmacy

Recently opened pharmacies to receive share of COVID-19 advance sums

Pandemic Delivery Service extended for patients in local outbreak areas

Self-isolation period extended to 10 days

July edition of CPN magazine is out

Government commits to NHS workforce development

New research on key role of community pharmacy in COVID-19 pandemic

Reminder: One week left to claim £300 payment for adjustments to support social distancing

Endorsing non-Part VIII EPS items

Have your say on the future of pharmacy representation​

Contractor Notice: Further extension to SSP06 – Fluoxetine 40mg capsules

Availability of Evorel products (Theramex) – Updated

Further additions made to July 2020 Price Concessions

Supply Notification: Sulfasalazine 250mg/5ml oral suspension sugar free (Rosemont) – Update

Medicine Supply Notification: Pethidine 50mg tablets

Rollout of EPS Phase 4 for SystmOne and EMIS prescribers

Reported drug quota issues – update

Brexit: DHSC plans for end of Transition Period

Class 2 Medicines recall: Clexane 4,000 IU (40mg) /0.4ml Syringes (Pharmaram Ltd)

Class 4 Medicines Defect Information: SyreniRing 0.120 mg/0.015 mg per 24 hours, vaginal delivery system (Crescent Pharma Ltd)